Page last updated: 2024-11-05

trifluoperazine and B16 Melanoma

trifluoperazine has been researched along with B16 Melanoma in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Nifedipine was included as the standard or reference compound."1.28In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II). ( Honn, KV; Nelson, KK; Onoda, JM; Taylor, JD, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Onoda, JM1
Nelson, KK1
Taylor, JD1
Honn, KV1
Ganapathi, R1
Schmidt, H1
Grabowski, D1
Melia, M1
Ratliff, N1

Other Studies

2 other studies available for trifluoperazine and B16 Melanoma

ArticleYear
In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Cancer research, 1989, Jun-01, Volume: 49, Issue:11

    Topics: Animals; Calcium Channel Blockers; Cisplatin; Diltiazem; Drug Evaluation, Preclinical; Drug Resistan

1989
Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
    British journal of cancer, 1988, Volume: 58, Issue:3

    Topics: Animals; Cell Survival; Doxorubicin; Drug Interactions; Drug Resistance; In Vitro Techniques; Lung N

1988